Our research focuses on saving and improving lives for people with GI cancers. We have a rich history of conducting practice-changing clinical trials and cutting-edge translational research. We invite you to view our research accomplishments and track record in publishing clinical trial research results and scientific outputs.
As a research group, our value and point of difference is multifaceted:
- We are multi-disciplinary and encourage diversity;
- Our research is collaborative and clinician-led;
- Community members with a lived GI cancer experience meaningfully inform our research;
- Our research focuses on patient needs in Australia and Aotearoa New Zealand;
- Translational and quality of life research is incorporated alongside and within clinical research; and
- We facilitate national and international multicentre research.
Opportunities for research development and collaboration
We encourage investigators to bring research concepts forward through the various avenues and opportunities offered:
- The Concept Proposal Form, where concepts can be submitted at any time
- The New Concepts Symposium at the Annual Scientific Meeting, where novel concepts are presented for feedback
- Idea Generation Workshops, where ideas are submitted and developed into research concepts for areas of unmet need
- The Translational Research Model, which enables the development of translational research in collaboration with basic scientists, preclinical and industry partners.
How we develop research
The challenges of treating GI cancers are vast so we are required to make pragmatic decisions, often weighing up the level of need with the feasibility to undertake certain research. Over time we have refined robust and transparent processes for idea generation and for translating ideas into concepts and ultimately into viable research studies, to provide our committees and members with confidence in our research portfolio.
Our current research focus is in treatment and translation. However, research in prevention and screening, diagnosis and survivorship are all identified as areas of growth and potential collaboration.
Our research is funded from a diverse range of sources including government grants and pharmaceutical industry support, and increasingly through philanthropy and community fundraising.
We partner with industry and collaborative organisations to further develop our research.
Learn how you can develop research with us
The Research Prioritisation and Development Framework (RPDF)
Our Research Prioritisation and Development Framework provides a streamlined, collaborative process that reviews and refines research concepts based on scientific merit, feasibility, alignment with our strategy, likelihood of funding, and organisational and financial risk:
Learn more about the committees involved in this process: